NCT07404774 Hemorrhoid Suture Mucopexy Combined With Laser Hemorrhoidoplasty
| NCT ID | NCT07404774 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National and Kapodistrian University of Athens |
| Condition | Haemorrhoid |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-01-01 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective cohort study evaluates whether combining "suture mucopexy" (a simple stitch-based lift of prolapsed tissue) with Laser Hemorrhoidoplasty (LHP) can effectively relieve pain, bleeding and prolapse in adults with moderate-to-severe hemorrhoids (Grades II-IV). Participants will undergo the combined, non-Doppler-guided procedure and be followed for one year. The primary question is how long patients need post-operative pain medication and if they first experience complete symptom relief; secondary questions examine quality-of-life, safety (bleeding, urinary retention, stenosis) and the rate of hemorrhoid recurrence/re-operation.
Eligibility Criteria
Inclusion Criteria: * Adults (\>18 years). * Symptomatic Hemorrhoidal Disease (Goligher Grades II, III, IV). * Patients with or without recurrent disease after prior procedures (e.g., RBL, infrared coagulation, Milligan-Morgan, etc). Exclusion Criteria: * Acutely thrombosed hemorrhoids. * Concomitant anal fistula or abscess requiring separate surgical management. * IBD (Crohn's/Ulcerative Colitis) with active rectal involvement. * Previous Stapled Haemorrhoidopexy (SH/Longo).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07404774 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Haemorrhoid. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07404774 currently recruiting?
Yes, NCT07404774 is actively recruiting participants. Contact the research team at georgetheocrs@live.com for enrollment information.
Where is the NCT07404774 trial being conducted?
This trial is being conducted at Athens, Greece.
Who is sponsoring the NCT07404774 clinical trial?
NCT07404774 is sponsored by National and Kapodistrian University of Athens. The trial plans to enroll 100 participants.